Follow-The-Filings

Holders · period archive

SGMT · Sagimet Biosciences Inc-A

Q2 2026 13F holders among managers we track latest ownership dossier

Ticker
SGMT
Type
Equity
Class
COM SER A
Total reported value ($000, long equity)
Manager Report date Value Shares